3.80
price up icon3.26%   0.12
pre-market  プレマーケット:  4.00   0.20   +5.26%
loading
前日終値:
$3.68
開ける:
$3.71
24時間の取引高:
571.43K
Relative Volume:
0.84
時価総額:
$229.60M
収益:
$40.37M
当期純損益:
$-119.72M
株価収益率:
-1.8626
EPS:
-2.0402
ネットキャッシュフロー:
$-135.06M
1週間 パフォーマンス:
+0.93%
1か月 パフォーマンス:
-8.21%
6か月 パフォーマンス:
-9.09%
1年 パフォーマンス:
+27.09%
1日の値動き範囲:
Value
$3.71
$3.895
1週間の範囲:
Value
$3.36
$3.895
52週間の値動き範囲:
Value
$2.645
$5.55

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name
名前
Voyager Therapeutics Inc
Name
セクター
Healthcare (1106)
Name
電話
857-259-5340
Name
住所
75 HAYDEN AVENUE, LEXINGTON, MA
Name
職員
141
Name
Twitter
@VoyagerTx
Name
次回の収益日
2026-05-05
Name
最新のSEC提出書
Name
VYGR's Discussions on Twitter

Compare VYGR vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
VYGR icon
VYGR
Voyager Therapeutics Inc
3.80 222.35M 40.37M -119.72M -135.06M -2.0402
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
434.52 110.03B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
638.88 67.37B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
806.46 50.76B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
297.45 40.12B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
151.56 32.68B 742.00K -1.37B -1.07B -7.0731

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 開始されました Cantor Fitzgerald Overweight
2024-12-02 開始されました Citigroup Buy
2024-11-29 再開されました Wedbush Outperform
2024-10-16 開始されました Leerink Partners Outperform
2024-03-26 開始されました Guggenheim Buy
2024-03-19 開始されました H.C. Wainwright Buy
2024-03-07 開始されました Citigroup Buy
2024-01-02 アップグレード Wells Fargo Equal Weight → Overweight
2023-05-10 開始されました Truist Buy
2023-03-10 開始されました Oppenheimer Outperform
2021-10-07 アップグレード Robert W. Baird Neutral → Outperform
2021-02-26 ダウングレード Robert W. Baird Outperform → Neutral
2021-02-03 ダウングレード BTIG Research Buy → Neutral
2021-02-03 ダウングレード Wedbush Outperform → Neutral
2020-12-24 ダウングレード Cantor Fitzgerald Overweight → Neutral
2020-12-23 ダウングレード Raymond James Outperform → Mkt Perform
2020-11-11 ダウングレード Oppenheimer Outperform → Perform
2020-11-10 ダウングレード Raymond James Strong Buy → Outperform
2020-11-10 ダウングレード Wells Fargo Overweight → Equal Weight
2020-03-19 開始されました The Benchmark Company Buy
2020-02-06 開始されました Oppenheimer Outperform
2018-11-15 アップグレード Raymond James Outperform → Strong Buy
2018-09-10 再開されました BTIG Research Buy
2018-09-10 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-06-04 開始されました H.C. Wainwright Buy
2018-03-12 ダウングレード Evercore ISI Outperform → In-line
2018-03-12 ダウングレード Wedbush Outperform → Neutral
2018-02-02 開始されました Morgan Stanley Overweight
2017-11-28 再開されました Piper Jaffray Overweight
2017-10-31 開始されました Robert W. Baird Outperform
2017-10-27 開始されました Canaccord Genuity Buy
2017-10-23 繰り返されました Stifel Buy
2017-10-12 開始されました Raymond James Outperform
2017-08-17 開始されました Evercore ISI Outperform
2017-07-28 再開されました Stifel Buy
すべてを表示

Voyager Therapeutics Inc (VYGR) 最新ニュース

pulisher
May 22, 2026

Voyager Therapeutics Inc. (VYGR) Q1 2026 Earnings: Narrowed Loss Meets Optimism in Gene Therapy PipelineEPS Consistency Score - Newser

May 22, 2026
pulisher
May 22, 2026

Voyager Therapeutics Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market ResponseNet Income Trends - Newser

May 22, 2026
pulisher
May 22, 2026

Voyager Therapeutics (VYGR) Shares Rebound 4.76% as Biotech Sector Shows StrengthCrowd Risk Alerts - Newser

May 22, 2026
pulisher
May 20, 2026

- Insider Monkey

May 20, 2026
pulisher
May 20, 2026

What Voyager Therapeutics Inc (VYGR) Has Gained on Its Therapy Programs - Insider Monkey

May 20, 2026
pulisher
May 18, 2026

Voyager Therapeutics (VYGR) accounting officer reports initial share and option holdings - Stock Titan

May 18, 2026
pulisher
May 17, 2026

The one question every Voyager Therapeutics VYGR investor should ask Bullish Sentiment 20260510High Attention Stocks - Newser

May 17, 2026
pulisher
May 15, 2026

VYGR (NASDAQ: VYGR) affiliate files Form 144 to sell 25,000 shares - Stock Titan

May 15, 2026
pulisher
May 15, 2026

EcoR1 and Oleg Nodelman report 0 shares in Voyager (NASDAQ: VYGR) amendment - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Armistice Capital (VYGR) reports 3.5M shares, 5.87% stake in Voyager - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Voyager Therapeutics (NASDAQ: VYGR) affiliate files to sell 9,406 shares - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Wedbush Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $8 - Moomoo

May 15, 2026
pulisher
May 14, 2026

TradingKey - TradingKey

May 14, 2026
pulisher
May 14, 2026

VYGR Technical Analysis | Trend, Signals & Chart Patterns | VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) - ChartMill

May 14, 2026
pulisher
May 13, 2026

Voyager presents preclinical data for Alzheimer’s gene therapy By Investing.com - Investing.com India

May 13, 2026
pulisher
May 13, 2026

Voyager Therapeutics (VYGR) Reports Positive Findings for Alzhei - GuruFocus

May 13, 2026
pulisher
May 13, 2026

VYGR Secures Mission Management Contract for ISS Research - GuruFocus

May 13, 2026
pulisher
May 13, 2026

Voyager presents preclinical data for Alzheimer’s gene therapy - Investing.com UK

May 13, 2026
pulisher
May 13, 2026

Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026 - The Manila Times

May 13, 2026
pulisher
May 13, 2026

Voyager Therapeutics Advances VY1706 Gene Therapy for Alzheimer's Disease with IND Application on Track for Q2 2026 - Quiver Quantitative

May 13, 2026
pulisher
May 13, 2026

Voyager Therapeutics Presents Three-Month GLP Toxicology Data For VY1706 And Provides Updates On Gene Therapy Pipeline - marketscreener.com

May 13, 2026
pulisher
May 11, 2026

CCORF Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $12 - Moomoo

May 11, 2026
pulisher
May 10, 2026

The one question every Voyager Therapeutics (VYGR) investor should ask (Bullish Sentiment) 2026-05-10Social Momentum Signals - newser.com

May 10, 2026
pulisher
May 09, 2026

Voyager Therapeutics Announces CFO Resignation and Finance Leadership Changes - TipRanks

May 09, 2026
pulisher
May 09, 2026

Voyager Therapeutics (NASDAQ:VYGR) Rating Lowered to Sell at Wall Street Zen - MarketBeat

May 09, 2026
pulisher
May 09, 2026

Voyager Therapeutics Warns of Broad Risk Exposure and Uncertain Outlook in Latest SEC Filings - TipRanks

May 09, 2026
pulisher
May 08, 2026

Voyager Therapeutics stock (US92916U1025): Q1 2026 results and pipeline updates drive sentiment - AD HOC NEWS

May 08, 2026
pulisher
May 08, 2026

Voyager Therapeutics (VYGR) reports Q1 loss, misses revenue estimates - MSN

May 08, 2026
pulisher
May 08, 2026

Voyager Therapeutics: Q1 Earnings Snapshot - theheraldreview.com

May 08, 2026
pulisher
May 07, 2026

Voyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 07, 2026
pulisher
May 07, 2026

Alzheimer’s gene therapy moves toward human testing as cash lasts into 2028 - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Voyager Therapeutics (Nasdaq: VYGR) posts Q1 2026 loss and advances tau drugs - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Voyager Therapeutics (Nasdaq: VYGR) trims Q1 2026 loss, holds $171.7M cash - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Voyager Reports First Quarter 2026 Financial and Operating Results - marketscreener.com

May 07, 2026
pulisher
May 06, 2026

VOYAGER THERAPEUTICS, INC. (VYGR) - MSN

May 06, 2026
pulisher
May 05, 2026

Voyager Therapeutics CFO resigns; Robin Swartz takes financial charge - MSN

May 05, 2026
pulisher
May 05, 2026

The key driver behind Voyager Therapeutics (VYGR) revenue growth | Q4 2025: Better Than ExpectedDividend Report - Newser

May 05, 2026
pulisher
May 04, 2026

MSN Money - MSN

May 04, 2026
pulisher
May 02, 2026

Voyager Therapeutics Inc (VYGR) - MSN

May 02, 2026
pulisher
May 01, 2026

Voyager Therapeutics Inc expected to post a loss of 53 cents a shareEarnings Preview - TradingView

May 01, 2026
pulisher
May 01, 2026

Voyager Therapeutics (VYGR) Stock: Support Breakdown Risk | Q4 2025: EPS Beats ForecastsEBITDA Estimate Trend - Newser

May 01, 2026
pulisher
Apr 30, 2026

H.C. Wainwright Reaffirms Their Buy Rating on Voyager Therapeutics (VYGR) - The Globe and Mail

Apr 30, 2026
pulisher
Apr 29, 2026

H.C. Wainwright Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $25 - Moomoo

Apr 29, 2026

Voyager Therapeutics Inc (VYGR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$29.96
price down icon 2.98%
$106.24
price down icon 3.00%
$92.14
price up icon 1.33%
$54.50
price up icon 1.77%
ONC ONC
$310.25
price up icon 0.20%
$151.56
price down icon 1.41%
大文字化:     |  ボリューム (24 時間):